FIND BEST PRACTICES FROM OTHER OPHTHALMOLOGISTS

FIND RESOURCES TO SUPPORT MANAGEMENT OF RETINAL DISEASE

CONGRESSES & EVENTS

ADVOCACY & PARTNERSHIPS

RESEARCH & FELLOWSHIP GRANTS

This website contains information on EYLEA® (aflibercept solution for injection) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA and UK. In countries outside the EU the local Product Information applies.

PP-EYL-ALL-0513-1. Last updated on 29/02/2020